The clinical manifestations caused by ASH1L mutations are extensive phenotypic heterogeneity, such as intellectual disability, autosomal dominant 52 (MRD) [13,14] and Tourette syndrome [15], suggesting the common genetic risk of ASH1L for clinically distinct syndromes. Here, ASH1L is linked to Tourette syndrome.